HPV-positive HNSCC have an improved clinical outcome [8, 57] and a lower median CD73 expression (Fig. 2 in [64]), which represents a confounder when analyzing prognostic values of CD73. This evidence concerns the gene NT5E and head and neck squamous cell carcinoma.